Roche Taps Stefano Mazzone to Lead Egyptian Market Amid Health Reforms

Roche has appointed Stefano Mazzone as the new General Manager of Roche Egypt, placing him at the helm of the company’s operations at a time when the country’s healthcare system is going through steady change.

The move comes as Egypt continues to prioritise broader access to care, improved quality standards and a more sustainable healthcare model. Roche, which operates globally across pharmaceuticals and diagnostics, says its work in Egypt will remain rooted in long-term partnerships and a sharp focus on areas where patient and societal needs are most pressing.

Mazzone steps into the role with experience gained across several markets. Over the years, he has held positions within Roche in Europe and Italy, at the company’s Pharma International headquarters in Switzerland, across the EEMEA region, and in the Middle East, including the UAE. Much of his career has centred on healthcare transformation, market access and building ecosystem partnerships that support sustainable access to innovation.

In a statement, Mazzone described himself as “honored” to take on the role as Egypt advances what he called an important healthcare journey. He also noted a personal affinity with the country’s history and culture, adding that he looks forward to listening and working closely with stakeholders across the healthcare ecosystem, in line with Roche’s purpose of “doing now what patients need next”.

If you’ve followed Egypt’s health reforms in recent years, you’ll know this isn’t just corporate speak. The country has been pushing ahead with universal health insurance reforms and digitalisation efforts, and global pharma players are watching closely. For Roche, being part of the Africa region within its global network means Egypt is more than just another market; it’s a strategic base for collaboration and shared learning.

I remember attending a health innovation forum in Cairo a few years back, where startup founders were pitching digital health tools to crowded rooms of investors and pharma executives. The energy was palpable. You could feel that something was shifting. In that context, leadership appointments like this one are not just routine reshuffles; they can shape how multinational players plug into local ecosystems. And for entrepreneurs building in health tech, that can be spot on timing.

Roche, founded in Basel in 1896, now operates in over 150 countries and focuses on areas including oncology, neurology, cardiovascular and metabolic diseases, ophthalmology, infectious diseases and immunology. It combines diagnostics, medicines and digital tools in an effort to prevent, stop and cure diseases, a big ambition, no doubt about it.

That said, leadership success in markets like Egypt often comes down to understanding local nuance. It’s one thing to roll out global strategy; it’s another to navigate reimbursement pathways, public-private partnerships and on-the-ground patient realities without it becoming a bit of a faff. I reckon Mazzone’s cross-regional background could help bridge that gap, although the real test will always be in execution.

On the flip side, Egypt’s healthcare transformation is still a work in progress. Expanding access while keeping the system financially sustainable is no small feat. But with continued collaboration between multinationals, regulators and homegrown startups, there is definately room for progress.

For readers at Arageek who keep a close eye on how global giants intersect with local innovation, this appointment is worth noting. Sometimes these shifts feel subtle at first. Then, well… I mean, a few years later you look back and realise they were part of a much bigger story unfolding across the region.

🚀 Got exciting news to share?

If you're a startup founder, VC, or PR agency with big updates—funding rounds, product launches 📢, or company milestones 🎉 — AraGeek English wants to hear from you!

✉️ Send Us Your Story 👇

https://en.arageek.com/send-us-your-story-or-a-news-tip